Genomic Vision Société Anonyme

ENXTPA:GV Stok Raporu

Piyasa değeri: €692.9k

Genomic Vision Société Anonyme Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Genomic Vision Société Anonyme has a total shareholder equity of €-2.8M and total debt of €457.0K, which brings its debt-to-equity ratio to -16.5%. Its total assets and total liabilities are €4.0M and €6.7M respectively.

Anahtar bilgiler

-16.5%

Borç/özkaynak oranı

€457.00k

Borç

Faiz karşılama oranın/a
Nakit€14.00k
Eşitlik-€2.77m
Toplam yükümlülükler€6.73m
Toplam varlıklar€3.96m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

If You Had Bought Genomic Vision Société Anonyme (EPA:GV) Shares A Year Ago You'd Have Earned 175% Returns

Dec 23
If You Had Bought Genomic Vision Société Anonyme (EPA:GV) Shares A Year Ago You'd Have Earned 175% Returns

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: GV has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Uzun Vadeli Yükümlülükler: GV has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: GV has negative shareholder equity, which is a more serious situation than a high debt level.

Borcun Azaltılması: GV's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: GV has less than a year of cash runway based on its current free cash flow.

Tahmini Nakit Akışı: GV has less than a year of cash runway if free cash flow continues to grow at historical rates of 10.3% each year.


Sağlıklı şirketleri keşfedin